Stock Analysis

Unibios Holdings Full Year 2023 Earnings: EPS: €0.12 (vs €0.042 in FY 2022)

ATSE:BIOSK

Unibios Holdings (ATH:BIOSK) Full Year 2023 Results

Key Financial Results

  • Revenue: €13.0m (up 15% from FY 2022).
  • Net income: €2.03m (up 212% from FY 2022).
  • Profit margin: 16% (up from 5.8% in FY 2022). The increase in margin was driven by higher revenue.
  • EPS: €0.12 (up from €0.042 in FY 2022).
ATSE:BIOSK Earnings and Revenue History May 1st 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Unibios Holdings shares are up 7.0% from a week ago.

Risk Analysis

Before you take the next step you should know about the 1 warning sign for Unibios Holdings that we have uncovered.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.